Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1991 Feb;102(2):439–445. doi: 10.1111/j.1476-5381.1991.tb12192.x

Mechanisms underlying the differential sensitivity to alpha 1-adrenoceptor activation in the bisected rat vas deferens.

J Sallés 1, A Badia 1
PMCID: PMC1918043  PMID: 1673073

Abstract

1. The factors underlying the different responsiveness of the prostatic and epididymal portions of rat vas deferens to alpha 1-adrenoceptor stimulation were investigated. 2. The alpha 1-adrenoceptors in membranes of both halves of rat vas deferens were labelled with [3H]-prazosin and the affinities of agonists and antagonists for these receptors were determined. In saturation studies, the Bmax and KD values for [3H]-prazosin in membranes of both portions were the same. 3. In competition studies, the inhibition curves for phentolamine were biphasic and consistent with the presence of both alpha 1a- and alpha 1b-adrenoceptor subtypes. The proportions of binding sites with high and low affinity for phentolamine in both halves of rat vas deferens were similar and in good agreement with the percentages of binding sites for WB-4101 and phentolamine previously reported in the whole rat vas deferens. 4. The phenylethylamines displaced [3H]-prazosin with a shallow inhibition curve. The data are compatible with the assumption of two affinity states for the binding sites. For the imidazoline compounds no such distinct affinity states could be demonstrated. 5. The affinity for, and the relative intrinsic efficacy on postsynaptic alpha 1-adrenoceptors of both portions of rat vas deferens were studied for noradrenaline, phenylephrine and methoxamine by irreversible inactivation of the alpha 1-adrenoceptors by phenoxybenzamine. The parameters for partial agonists were determined by comparing the responses to the partial agonist to those of a full agonist in the same tissue. Homogeneous estimates of the equilibrium dissociation constants (Ka) were obtained, indicating that these agonists bind to the receptors of both tissues in an identical manner.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
439

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ARUNLAKSHANA O., SCHILD H. O. Some quantitative uses of drug antagonists. Br J Pharmacol Chemother. 1959 Mar;14(1):48–58. doi: 10.1111/j.1476-5381.1959.tb00928.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Altura B. M., Altura B. T. Heterogeneity of drug receptors in different segments of rabbit thoracic aorta. Eur J Pharmacol. 1970 Sep 1;12(1):44–52. doi: 10.1016/0014-2999(70)90027-0. [DOI] [PubMed] [Google Scholar]
  3. Badia A., Sallés J. Effects of St-587 on the alpha-adrenoceptors in the bisected rat vas deferens. J Pharm Pharmacol. 1989 Sep;41(9):612–616. doi: 10.1111/j.2042-7158.1989.tb06541.x. [DOI] [PubMed] [Google Scholar]
  4. Brown D. A., Docherty J. R., French A. M., MacDonald A., McGrath J. C., Scott N. C. Separation of adrenergic and non-adrenergic contractions to field stimulation in the rat vas deferens. Br J Pharmacol. 1983 Jun;79(2):379–393. doi: 10.1111/j.1476-5381.1983.tb11010.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Díaz-Toledo A., Martí M. C. Relationship between alpha-adrenoceptor occupancy and contractile response in rat vas deferens. Experimental and theoretical analysis. Eur J Pharmacol. 1988 Nov 8;156(3):315–324. doi: 10.1016/0014-2999(88)90276-2. [DOI] [PubMed] [Google Scholar]
  6. Ernsberger P., U'Prichard D. C. Modulation of agonist and antagonist interactions at kidney alpha 1-adrenoceptors by nucleotides and metal ions. Eur J Pharmacol. 1987 Jan 13;133(2):165–176. doi: 10.1016/0014-2999(87)90147-6. [DOI] [PubMed] [Google Scholar]
  7. Gintautas J., Kraynack B. J., Racz G. B. Responsiveness of isolated cerebral arteries to various pharmacologic agents and to transmural electrical stimulation. Proc West Pharmacol Soc. 1980;23:63–67. [PubMed] [Google Scholar]
  8. Gross G., Hanft G., Rugevics C. U. Alpha 1-adrenoceptors of rat myocardium: comparison of agonist binding and positive inotropic response. Naunyn Schmiedebergs Arch Pharmacol. 1988 Nov;338(5):582–588. doi: 10.1007/BF00179334. [DOI] [PubMed] [Google Scholar]
  9. Han C., Abel P. W., Minneman K. P. Alpha 1-adrenoceptor subtypes linked to different mechanisms for increasing intracellular Ca2+ in smooth muscle. Nature. 1987 Sep 24;329(6137):333–335. doi: 10.1038/329333a0. [DOI] [PubMed] [Google Scholar]
  10. Hanft G., Gross G., Beckeringh J. J., Korstanje C. Alpha 1-adrenoceptors: the ability of various agonists and antagonists to discriminate between two distinct [3H]prazosin binding sites. J Pharm Pharmacol. 1989 Oct;41(10):714–716. doi: 10.1111/j.2042-7158.1989.tb06348.x. [DOI] [PubMed] [Google Scholar]
  11. Hanft G., Gross G. Subclassification of alpha 1-adrenoceptor recognition sites by urapidil derivatives and other selective antagonists. Br J Pharmacol. 1989 Jul;97(3):691–700. doi: 10.1111/j.1476-5381.1989.tb12005.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kasuya Y., Suzuki N. Variation of postjunctional natures along the length of the rat vas deferens as a cause of regional difference in the sensitivity to norepinephrine. Arch Int Pharmacodyn Ther. 1979 Sep;241(1):24–31. [PubMed] [Google Scholar]
  13. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  14. Levin R. M., Wein A. J. Distribution and function of adrenergic receptors in the urinary bladder. Mol Pharmacol. 1979 Sep;16(2):441–448. [PubMed] [Google Scholar]
  15. MacDonald A., McGrath J. C. The distribution of adrenoceptors and other drug receptors between the two ends of the rat vas deferens as revealed by selective agonists and antagonists. Br J Pharmacol. 1980;71(2):445–458. doi: 10.1111/j.1476-5381.1980.tb10957.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. McGrath J. C. Adrenergic and 'non-adrenergic' components in the contractile response of the vas deferens to a single indirect stimulus. J Physiol. 1978 Oct;283:23–39. doi: 10.1113/jphysiol.1978.sp012486. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. McGrath J. C. Alpha-adrenoceptor antagonism by apoyohimbine and some observations on the pharmacology of alpha-adrenoceptors in the rat anococcygeus and vas deferens. Br J Pharmacol. 1984 Aug;82(4):769–781. doi: 10.1111/j.1476-5381.1984.tb16473.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. McPherson G. A. A practical computer-based approach to the analysis of radioligand binding experiments. Comput Programs Biomed. 1983 Aug-Oct;17(1-2):107–113. doi: 10.1016/0010-468x(83)90031-4. [DOI] [PubMed] [Google Scholar]
  19. Minneman K. P., Abel P. W. "Spare" alpha 1-adrenergic receptors and the potency of agonists in rat vas deferens. Mol Pharmacol. 1984 Jan;25(1):56–63. [PubMed] [Google Scholar]
  20. Minneman K. P., Fox A. W., Abel P. W. Occupancy of alpha 1-adrenergic receptors and contraction of rat vas deferens. Mol Pharmacol. 1983 Mar;23(2):359–368. [PubMed] [Google Scholar]
  21. Moore P. K., Griffiths R. J. Pre-synaptic and post-synaptic effects of xylazine and naphazoline on the bisected rat vas deferens. Arch Int Pharmacodyn Ther. 1982 Nov;260(1):70–77. [PubMed] [Google Scholar]
  22. Morrow A. L., Creese I. Characterization of alpha 1-adrenergic receptor subtypes in rat brain: a reevaluation of [3H]WB4104 and [3H]prazosin binding. Mol Pharmacol. 1986 Apr;29(4):321–330. [PubMed] [Google Scholar]
  23. Munson P. J., Rodbard D. Ligand: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem. 1980 Sep 1;107(1):220–239. doi: 10.1016/0003-2697(80)90515-1. [DOI] [PubMed] [Google Scholar]
  24. Vardolov L., Pennefather J. N. Regional variation in the distribution of alpha-adrenoreceptors in the vas deferens of the rat. Arch Int Pharmacodyn Ther. 1976 Jun;221(2):212–212. [PubMed] [Google Scholar]
  25. Waud D. R. On the measurement of the affinity of partial agonists for receptors. J Pharmacol Exp Ther. 1969 Nov;170(1):117–122. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES